Inactive Instrument

News IMCLONE SYSTEMS Nasdaq

Stocks

US45245W1099

End-of-day quote Nasdaq
- ^USD	-

-1-11-29	IMCLONE SYSTEMS : Lilly bids $6.5 billion for ImClone	RE
-1-11-29	IMCLONE SYSTEMS : Lilly to acquire ImClone Systems in $6.5 billion transaction	RE

All News

Mentions Relevance

-1-11-29	IMCLONE SYSTEMS : Lilly Commences Cash Tender Offer for ImClone Systems at $70 Per Share	PR
-1-11-29	IMCLONE SYSTEMS : Lilly bids $6.5 billion for ImClone	RE
-1-11-29	IMCLONE SYSTEMS : Lilly to acquire ImClone Systems in $6.5 billion transaction	RE
-1-11-29	IMCLONE SYSTEMS : ImClone set to be acquired by Eli Lilly: sources	RE
-1-11-29	IMCLONE SYSTEMS : ImClone set to be acquired by Eli Lilly for $6.1 bln: sources	RE
-1-11-29	IMCLONE SYSTEMS : ImClone to announce sale talks continuing: report	RE
-1-11-29	IMCLONE SYSTEMS : Icahn Responds to Cornelius	PR
-1-11-29	IMCLONE SYSTEMS : ImClone says it received $70-a-share buyout offer	RE
-1-11-29	IMCLONE SYSTEMS : ImClone says has received $70 share buyout offer	RE
-1-11-29	IMCLONE SYSTEMS : ImClone says hires JP Morgan to weigh options	RE
-1-11-29	IMCLONE SYSTEMS : ImClone hires JP Morgan to weigh options: sources	RE
-1-11-29	IMCLONE SYSTEMS : ImClone calls Bristol offer too low	RE
-1-11-29	IMCLONE SYSTEMS : ImClone to study Bristol offer	RE
-1-11-29	Imclone Systems : Seven Summits Research Releases Comments on QCOM, NOK, BUD, COF, and IMCL	PR
-1-11-29	Imclone Systems : ImClone Settles Patent Lawsuit and Gains Rights to Additional Intellectual Property	BU
-1-11-29	Imclone Systems : ImClone Systems to Present at the Bear Stearns Annual Healthcare Conference	BU
-1-11-29	Imclone Systems : Phase II Study of IMC-A12 for Advanced Prostate Cancer Commences Patient Enrollment	BU
-1-11-29	Imclone Systems : Phase II Study of IMC-1121B for Advanced Renal Cell Cancer Opens for Patient Enrollment	BU
-1-11-29	Imclone Systems : FDA Approves ImClone Systems' New State-of-the-Art Manufacturing Facility	BU
-1-11-29	Imclone Systems : ImClone Systems Appoints John H. Johnson Chief Executive Officer	BU
-1-11-29	Imclone Systems : Phase II Study of IMC-11F8 for Advanced Colorectal Cancer Has Commenced Patient Enrollment in Europe	BU
-1-11-29	Imclone Systems : ImClone Systems Reports Second Quarter 2007 Financial Results	BU
-1-11-29	Imclone Systems : ImClone Systems to Host 2007 Second Quarter Financial Results Conference Call	BU
-1-11-29	Imclone Systems : ImClone Systems to Host Annual Meeting of Stockholders on August 2, 2007	BU
-1-11-29	Imclone Systems : Phase II Study of IMC-A12 for Advanced Colorectal Cancer Has Commenced Patient Enrollment	BU